Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04903821
What this trial is testing

Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Bayer 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985
What this trial is testing

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 72
Not applicableEnded earlyNCT02908048
What this trial is testing

Extracellular RNA Markers of Liver Disease and Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract CancerCirrhosis+1 more
Mayo Clinic 1,865
Large-scale testing (Phase 3)UnknownNCT03338647
What this trial is testing

SBRT or TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
University of Aarhus 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05897138
What this trial is testing

Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Who this might be right for
Hepatocellular Carcinoma
Fujian Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05451043
What this trial is testing

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Who this might be right for
Pancreatic CancerHepatocellular CancerBiliary Tract Cancer+1 more
AHS Cancer Control Alberta 62
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Testing effectiveness (Phase 2)Ended earlyNCT04923776
What this trial is testing

Liver Directed RT + Chemo-immunotherapy for ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Brian Henick, MD 2
Testing effectiveness (Phase 2)Ended earlyNCT01032850
What this trial is testing

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
New Mexico Cancer Research Alliance 15
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Not applicableStudy completedNCT05146297
What this trial is testing

Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Who this might be right for
Breast CancerLiver CancerProstate Cancer
Icahn School of Medicine at Mount Sinai 585
Testing effectiveness (Phase 2)Study completedNCT04945720
What this trial is testing

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01835223
What this trial is testing

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaNon-Resectable Hepatocellular Carcinoma
Roswell Park Cancer Institute 33
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Not applicableLooking for participantsNCT06061276
What this trial is testing

BTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 40
Not applicableNot Yet RecruitingNCT07117279
What this trial is testing

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Tongji Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00855218
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).

Who this might be right for
Carcinoma, Hepatocellular
Bayer 307
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableStudy completedNCT07321613
What this trial is testing

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

Who this might be right for
Hepatocellular Cancer (HCC)
Shanghai Zhongshan Hospital 545
Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Next Page